Publications by authors named "Zerbib F"

Introduction: Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed.

View Article and Find Full Text PDF

Background: Many patients diagnosed with gastro-oesophageal reflux disease (GERD) have persistent symptoms despite proton pump inhibitor (PPI) therapy.

Aims: The aim of this consensus is to provide evidence-based statements to guide clinicians caring for patients with refractory reflux-like symptoms (rRLS) or refractory GERD.

Methods: This consensus was developed by the International Working Group for the Classification of Oesophagitis.

View Article and Find Full Text PDF

Background: There is limited comparative data on patients with inflammatory bowel disease (IBD) switched from intravenous to subcutaneous infliximab and those continuing intravenously. This study aimed to compare the persistence and tolerance of subcutaneous and intravenous infliximab and the outcomes of patients resuming intravenous infliximab.

Methods: We conducted a retrospective single-centre cohort study involving IBD patients treated with maintenance intravenous infliximab.

View Article and Find Full Text PDF

Introduction: The aim of this study was to compare the impact of the depth of myotomy (selective inner layer myotomy (SIM) vs. full-thickness myotomy (FTM)) on the outcome of patients treated with POEM for achalasia.

Methods: This was a retrospective, observational, conducted in two tertiary centers between October 2018 and September 2022.

View Article and Find Full Text PDF
Article Synopsis
  • High-resolution manometry (HRM) has significantly improved the diagnosis of foregut symptoms over the past 20 years, yet its role in assessing patients before and after antireflux surgery remains uncertain.
  • A multi-disciplinary group of 29 experts, including surgeons and gastroenterologists, collaborated to clarify the role of HRM in relation to antireflux surgery and to create a classification system for interpreting HRM findings.
  • The resulting Padova Classification aims to enhance understanding and communication of HRM results for patients undergoing antireflux surgery, based on a thorough literature review and agreement among the experts.
View Article and Find Full Text PDF

Background: Non-randomised studies assessing intrarectal botulinum toxin type A (BoNTA) injections for faecal incontinence are promising. We aimed to evaluate the efficacy of BoNTA for the treatment of faecal incontinence in a randomised study.

Methods: In this randomised, double-blind, placebo-controlled study, we included adult patients who had at least one urgency or faecal incontinence episode per week for at least 3 months and who had experienced a failure of conservative or surgical treatment from eight French specialist hospital units with the skills to manage patients with faecal incontinence.

View Article and Find Full Text PDF
Article Synopsis
  • Achalasia is effectively treated with peroral endoscopic myotomy (POEM), but factors that contribute to early failure in treatment need further investigation, particularly in European populations.
  • A retrospective study of 746 patients revealed an early failure rate of 9.4%, with significant predictors including age ≤45 years, achalasia types I and III, and severe adverse events during the procedure.
  • The study highlighted that a high Eckardt score before the procedure is also a key factor, emphasizing the need to monitor retrosternal pain levels post-operation for better outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The Lyon Consensus 2.0 outlines updated criteria for diagnosing gastro-oesophageal reflux disease (GERD), incorporating findings from recent research to refine diagnostic strategies.
  • It distinguishes between unproven and proven GERD, recommending specific testing methods like prolonged wireless pH monitoring for unclear cases and pH-impedance monitoring for confirmed GERD patients.
  • Major changes include new diagnostic thresholds and the retirement of poor-performing criteria, aiming for a more personalized approach to GERD management based on individual patient symptoms and test results.
View Article and Find Full Text PDF

Background: Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC).

Aims: To investigate the connection between CRP elevation and deep ulcers in UC.

Methods: Patients with active UC were enrolled in a multicenter prospective cohort and a retrospective cohort of consecutive patients undergoing colectomy from 2012 to 2019.

View Article and Find Full Text PDF

Background: Chronic constipation (CC) is a frequent condition, and the first-line treatment includes dietary rules, the use of laxatives, and biofeedback for evacuation disorders. However, almost half of the patients are dissatisfied with their current treatment. We report the first double-blind randomized multicenter trial assessing the effectiveness of transabdominal electrical stimulation by interferential therapy (IFT) in the treatment of CC in adults.

View Article and Find Full Text PDF

Background: Recent data regarding the impact of biologics and new surgical techniques on the indications and outcomes of colectomy for ulcerative colitis (UC) are limited.

Aims: The present study aimed at determining the trend of colectomy in UC by comparing colectomy indications and outcomes between 2000 and 2010 and 2011-2020.

Methods: This observational retrospective study was conducted in two tertiary hospitals, including consecutive patients who underwent colectomy between 2000 and 2020.

View Article and Find Full Text PDF

Background: Both gastric electrical stimulation (GES) and gastric-peroral endoscopic myotomy (G-POEM) can be offered to patients with gastroparesis and predominant nausea and vomiting. The study's aim was to compare GES and G-POEM efficacy on nausea and vomiting scores in patients with gastroparesis.

Methods: Two multicenter cohorts of patients with medically refractory gastroparesis with predominant nausea and vomiting (defined as a score >2 on nausea and vomiting subscale that varied from 0 to 4) were treated either with GES (n = 34) or G-POEM (n = 30) and were followed for 24 months (M).

View Article and Find Full Text PDF
Article Synopsis
  • Variants in the PRSS1 and PRSS2 genes are linked to chronic pancreatitis (CP), prompting research into whether a deletion variant affecting two trypsinogen pseudogenes (PRSS3P2 and TRY7) might influence CP risk.
  • A study analyzed this deletion in over 4,000 participants from different countries and found that it is associated with a protective effect against CP, especially in French, German, and Japanese populations.
  • The research suggests that the deletion enhances the function of remaining genes, leading to regulated PRSS2 expression, which could be crucial in understanding CP susceptibility.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of ustekinumab and anti-TNF agents as first-line treatments in biologic-naïve patients with luminal Crohn's disease, focusing on clinical response rates at 3 months.
  • A total of 206 biologic-naïve patients (156 on anti-TNF agents and 50 on ustekinumab) were evaluated, with response rates at 3 months showing 64% for ustekinumab and 86% for anti-TNF agents, indicating a significant advantage for anti-TNF therapy (P = .01).
  • The findings suggest that anti-TNF agents lead to higher response rates within 3 months compared to ustekinumab, although no significant
View Article and Find Full Text PDF
Article Synopsis
  • Budesonide is the main treatment for microscopic colitis (MC), but frequent relapses and some patients being intolerant lead to the exploration of anti-TNF therapy in those who do not respond to budesonide.
  • In a study of 14 budesonide-refractory MC patients treated with anti-TNF agents, 35.7% achieved clinical remission and 64.3% showed improvement in stool frequency after 12 weeks.
  • The study concludes that anti-TNF therapy can be effective for about half of patients with MC who fail budesonide, marking a significant finding in the treatment of this condition.
View Article and Find Full Text PDF

Introduction: Patients treated with biologics for inflammatory bowel disease (IBD) have an increased risk of severe infections. Real-life vaccination coverage in this population remains low despite international vaccination guidelines. The aim of this study was to evaluate the impact of a dedicated vaccination visit on vaccination coverage.

View Article and Find Full Text PDF

The quality of life (QOL) of patients with celiac disease (CD) can be altered by both symptoms of the disease and by the restrictions of the gluten-free diet (GFD). The objective was to determine the factors associated with better QOL in a large cohort of CD patients. A link to an online survey was sent to the members of the French Association of Gluten Intolerant People (AFDIAG).

View Article and Find Full Text PDF

Background: Home parenteral nutrition (HPN) is the recommended treatment in patients with chronic intestinal failure (CIF). HPN is associated with a worsening of patients' quality of life and has a dramatic impact on personal and familial daily life. Little is known about the informal caregiver burden of patients receiving HPN.

View Article and Find Full Text PDF

Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving symptoms in most cases, although up to 40% of GERD patients do not respond adequately to PPI therapy. Refractory GERD (rGERD) is one of the most challenging problems, given its impact on the quality of life and consumption of health care resources.

View Article and Find Full Text PDF